Skip to main content
CORZ logo

CORZ · Core Scientific, Inc./tx · Executive Compensation

Track CORZ — free
$17.99 +0.85 (+4.96%) At close · Sep 18
Market Cap
$5.55B
Shares
321.34M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Adam Sullivan $22,923,204
James Nygaard $9,680,354
Todd DuChene $7,420,639
Todd M. DuChene $7,420,639
Denise Sterling $6,125,647
Fiscal 2024
Executive Total
Adam Sullivan $41,938,321
Todd DuChene $15,428,680
Todd M. DuChene $15,428,680
Denise Sterling $4,812,212
Fiscal 2023
Executive Total
Adam Sullivan $890,791
Todd DuChene $492,408
Todd M. DuChene $492,408
Denise Sterling $392,100
Fiscal 2021
Executive Total
Michael Levitt $160,695,727
Todd M. DuChene $13,092,015
Michael Trzupek $9,510,824
B. Kevin Turner $275,721
Fiscal 2020
Executive Total
Michael Trzupek $13,878,152
B. Kevin Turner $10,049,446
Todd M. DuChene $1,095,049

Executive changes

Person Change Filed
Mark W. Adams Appointed 2026-07-29
Steve M. Smith Appointed 2026-05-26
Jorge Ray Appointed 2026-05-05
Elizabeth Crain Appointed 2025-05-16
Todd Becker Resigned 2025-05-16
Adam Sullivan Appointed 2025-05-13
Denise Sterling Resigned 2025-03-04
James P. Nygaard, Jr. Appointed 2025-03-04
Denise Sterling Resigned 2024-09-06
Eric Weiss Appointed 2024-01-23
Yadin Rozov Appointed 2024-01-23
Jarrod Patten Appointed 2024-01-23
Jordan Levy Appointed 2024-01-23
Jeffrey Booth Appointed 2024-01-23
Todd Becker Appointed 2024-01-23
Adam Sullivan Appointed 2024-01-23
Kneeland Youngblood Resigned 2024-01-23
Matthew Minnis Resigned 2024-01-23
Neal Goldman Resigned 2024-01-23
Darin Feinstein Resigned 2024-01-23
Jarvis Hollingsworth Resigned 2024-01-23
Michael Levitt Resigned 2024-01-23
Adam Sullivan Appointed 2023-08-07
Darin Feinstein Resigned 2023-08-07
Michael Levitt Resigned 2023-08-07
Key facts CIK 1839341 CUSIP 21874A106 13F (30d) 7 filings 7 filers Visit website Investor relations